Enoxaparin sodium injection

Product Description

Product Name : Enoxaparin Sodium Injection

Nombre del Producto : Enoxaparina sdica solucin Inyectable

Specification:  0.4ml ***0iu, 0.6ml ***0iu 

Package: 1syringe/box

Standard: BP&USP

Indications and Usage for Enoxaparin Sodium Injection

Prophylaxis of Deep Vein Thrombosis

Enoxaparin Sodium Injection is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE):

in patients undergoing abdominal surgery who are at risk for thromboembolic complications [see Clinical Studies *4.1

in patients undergoing hip replacement surgery, during and following hospitalization.

in patients undergoing knee replacement surgery.

in medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness.

Treatment of Acute Deep Vein Thrombosis

Enoxaparin Sodium Injection is indicated for:

the inpatient treatment of acute deep vein thrombosis with or without pulmonary embolism, when administered in conjunction with warfarin sodium.

the outpatient treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium.

Prophylaxis of Ischemic Complications of Unstable Angina and Non-Q-Wave Myocardial Infarction

Enoxaparin Sodium Injection is indicated for the prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, when concurrently administered with aspirin.

Treatment of Acute ST-Segment Elevation Myocardial Infarction

Enoxaparin Sodium Injection, when administered concurrently with aspirin, has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction or death in patients with acute ST-segment elevation myocardial infarction (STEMI) receiving thrombolysis and being managed medically or with percutaneous coronary intervention (PCI).

Enoxaparin Sodium Injection Dosage and Administration

All patients should be evaluated for a bleeding disorder before administration of Enoxaparin Sodium Injection, unless the medication is needed urgently. Since coagulation parameters are unsuitable for monitoring Enoxaparin Sodium Injection activity, routine monitoring of coagulation parameters is not required [see Warnings and Precautions (5.9)].

For subcutaneous use, Enoxaparin Sodium Injection should not be mixed with other injections or infusions.

For intravenous use (i.e., for treatment of acute STEMI), Enoxaparin Sodium Injection can be mixed with normal saline solution (0.9%) or 5% dextrose in water.

Enoxaparin Sodium Injection is not intended for intramuscular administration.

Related Keywords:  

China enoxaparin sodium injection manufacturers,China enoxaparin sodium injection suppliers,enoxaparin sodium injection from China professional pharmaceutical factory,one of the enoxaparin sodium injection leading brands from China, Biological products,Enoxaparin Sodium Injection manufacturers,Enoxaparin Sodium Injection